Agreement between In-Clinics and Virus Neutralization Tests in Detecting Antibodies against Canine Distemper Virus (CDV)

Core vaccinations and specific antibody titer evaluations are strongly recommended worldwide by all the vaccination guidelines. Virus neutralization (VN) is considered the gold standard for measuring antibody titer against canine distemper virus, but it is complex and time consuming, and the use of...

Full description

Bibliographic Details
Main Authors: Sara Meazzi, Joel Filipe, Alessandra Fiore, Santina Di Bella, Francesco Mira, Paola Dall’Ara
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/14/3/517
_version_ 1827624833562705920
author Sara Meazzi
Joel Filipe
Alessandra Fiore
Santina Di Bella
Francesco Mira
Paola Dall’Ara
author_facet Sara Meazzi
Joel Filipe
Alessandra Fiore
Santina Di Bella
Francesco Mira
Paola Dall’Ara
author_sort Sara Meazzi
collection DOAJ
description Core vaccinations and specific antibody titer evaluations are strongly recommended worldwide by all the vaccination guidelines. Virus neutralization (VN) is considered the gold standard for measuring antibody titer against canine distemper virus, but it is complex and time consuming, and the use of in-clinics tests would allow to obtain quicker results. The aim of this study was to evaluate the agreement of the commercial in-clinics VacciCheck test compared to VN. A total of 106 canine sera were analyzed using both methods. The best agreement was obtained using a protective threshold of ≥1:32. VacciCheck showed 95.5% sensitivity, 87.2% specificity, and 92.5% accuracy. The Cohen’s kappa coefficient between methods was 0.84 (CI 95% 0.73 to 0.95), revealing an optimal agreement between the two methods (<i>p</i> = 0.0073). The evaluation of discordant results reveal that most samples had less than 1.5 dilution difference, and that usually did not affect the classification as protected or non-protected. Results also suggest that, in dubious cases, especially when a protective result is expected, retesting is advisable. In conclusion, VacciCheck may be considered as a reliable instrument that may help the clinician in identifying the best vaccine protocol, avoiding unnecessary vaccination, and thus reducing the incidence of adverse effects.
first_indexed 2024-03-09T12:17:07Z
format Article
id doaj.art-baf1c03323a34eabb2a82fe9a9ff0f46
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-09T12:17:07Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-baf1c03323a34eabb2a82fe9a9ff0f462023-11-30T22:45:41ZengMDPI AGViruses1999-49152022-03-0114351710.3390/v14030517Agreement between In-Clinics and Virus Neutralization Tests in Detecting Antibodies against Canine Distemper Virus (CDV)Sara Meazzi0Joel Filipe1Alessandra Fiore2Santina Di Bella3Francesco Mira4Paola Dall’Ara5Department of Veterinary Medicine and Animal Sciences, University of Milan, 26900 Lodi, ItalyDepartment of Veterinary Medicine and Animal Sciences, University of Milan, 26900 Lodi, ItalyDepartment of Veterinary Medicine and Animal Sciences, University of Milan, 26900 Lodi, ItalyIstituto Zooprofilattico Sperimentale della Sicilia “A. Mirri”, 90129 Palermo, ItalyIstituto Zooprofilattico Sperimentale della Sicilia “A. Mirri”, 90129 Palermo, ItalyDepartment of Veterinary Medicine and Animal Sciences, University of Milan, 26900 Lodi, ItalyCore vaccinations and specific antibody titer evaluations are strongly recommended worldwide by all the vaccination guidelines. Virus neutralization (VN) is considered the gold standard for measuring antibody titer against canine distemper virus, but it is complex and time consuming, and the use of in-clinics tests would allow to obtain quicker results. The aim of this study was to evaluate the agreement of the commercial in-clinics VacciCheck test compared to VN. A total of 106 canine sera were analyzed using both methods. The best agreement was obtained using a protective threshold of ≥1:32. VacciCheck showed 95.5% sensitivity, 87.2% specificity, and 92.5% accuracy. The Cohen’s kappa coefficient between methods was 0.84 (CI 95% 0.73 to 0.95), revealing an optimal agreement between the two methods (<i>p</i> = 0.0073). The evaluation of discordant results reveal that most samples had less than 1.5 dilution difference, and that usually did not affect the classification as protected or non-protected. Results also suggest that, in dubious cases, especially when a protective result is expected, retesting is advisable. In conclusion, VacciCheck may be considered as a reliable instrument that may help the clinician in identifying the best vaccine protocol, avoiding unnecessary vaccination, and thus reducing the incidence of adverse effects.https://www.mdpi.com/1999-4915/14/3/517virus neutralizationVacciCheckcanine distemper virusantibody titervaccination
spellingShingle Sara Meazzi
Joel Filipe
Alessandra Fiore
Santina Di Bella
Francesco Mira
Paola Dall’Ara
Agreement between In-Clinics and Virus Neutralization Tests in Detecting Antibodies against Canine Distemper Virus (CDV)
Viruses
virus neutralization
VacciCheck
canine distemper virus
antibody titer
vaccination
title Agreement between In-Clinics and Virus Neutralization Tests in Detecting Antibodies against Canine Distemper Virus (CDV)
title_full Agreement between In-Clinics and Virus Neutralization Tests in Detecting Antibodies against Canine Distemper Virus (CDV)
title_fullStr Agreement between In-Clinics and Virus Neutralization Tests in Detecting Antibodies against Canine Distemper Virus (CDV)
title_full_unstemmed Agreement between In-Clinics and Virus Neutralization Tests in Detecting Antibodies against Canine Distemper Virus (CDV)
title_short Agreement between In-Clinics and Virus Neutralization Tests in Detecting Antibodies against Canine Distemper Virus (CDV)
title_sort agreement between in clinics and virus neutralization tests in detecting antibodies against canine distemper virus cdv
topic virus neutralization
VacciCheck
canine distemper virus
antibody titer
vaccination
url https://www.mdpi.com/1999-4915/14/3/517
work_keys_str_mv AT sarameazzi agreementbetweeninclinicsandvirusneutralizationtestsindetectingantibodiesagainstcaninedistemperviruscdv
AT joelfilipe agreementbetweeninclinicsandvirusneutralizationtestsindetectingantibodiesagainstcaninedistemperviruscdv
AT alessandrafiore agreementbetweeninclinicsandvirusneutralizationtestsindetectingantibodiesagainstcaninedistemperviruscdv
AT santinadibella agreementbetweeninclinicsandvirusneutralizationtestsindetectingantibodiesagainstcaninedistemperviruscdv
AT francescomira agreementbetweeninclinicsandvirusneutralizationtestsindetectingantibodiesagainstcaninedistemperviruscdv
AT paoladallara agreementbetweeninclinicsandvirusneutralizationtestsindetectingantibodiesagainstcaninedistemperviruscdv